BrandonHardestyMD(He/Him)
Hematology • Indianapolis, INClotting Disorder, Hemophilia & Bleeding Disorder, Sickle Cell & Other Anemias
Adult Hematologist
Dr. Hardesty is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8326 Naab Road
Indianapolis, IN 46260Phone+1 317-871-0000Fax+1 317-871-0010
Summary
- Dr. Brandon Hardesty is a Hematology specialist based in Indianapolis, Indiana with subspecialties in Hemophilia & Bleeding Disorder, and Sickle Cell & Other Anemias. He completed his fellowship in Hematology and Medical Oncology, as well as his residency in Internal Medicine, at Indiana University School of Medicine and is an alumnus of Ohio State University College of Medicine. He is currently a Clinical Assistant professor at Marian University College of Osteopathic Medicine and an Adult Hematologist at Indiana Hemophilia & Thrombosis Center. Dr. Hardesty has expertise in managing conditions like sickle-cell anemia, bleeding disorders, and plasminogen deficiency, and has contributed to multiple clinical trials and publications within these fields. He was recognized as a Top Doctor by Castle Connolly from 2019 to 2023.
Education & Training
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013- Indiana University School of MedicineResidency, Internal Medicine, 2006 - 2009
Ohio State University College of MedicineClass of 2006
Certifications & Licensure
IN State Medical License 2008 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Top Doctor Castle Connolly, 2019-2024
Clinical Trials
- Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A Start of enrollment: 2015 Dec 30
- A Study of Prometic Plasminogen IV Infusion in Subjects With Hypoplasminogenemia Start of enrollment: 2016 May 04
- Study to Evaluate the Effect of Voxelotor Administered Orally to Patients With Sickle Cell Disease (GBT_HOPE) Start of enrollment: 2016 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsInflammation and autoimmunity are interrelated in patients with sickle cell disease at a steady-state condition: implications for vaso-occlusive crisis, pain, and sens...Wei Li, Andrew Q Pucka, Candice Debats, Brandon A Reyes, Fahim Syed
Frontiers in Immunology. 2024-01-01 - Inflammation and autoimmunity are interrelated in patients with sickle cell disease at a steady-state condition: implications for vaso-occlusive crisis, pain, and sens...Wei Li, Andrew Q Pucka, Candice Debats, Brandon Reyes, Fahim Syed
Medrxiv. 2023-09-05 - Real-world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A non-interventional, post-authorization safety study.Michael D Tarantino, Brandon Hardesty, Ara Metjian, Thomas L Ortel, Jie Chen
Haemophilia. 2023-09-01
Abstracts/Posters
- Cardiovascular Disease Prevention in Persons with HemophiliaBrandon Hardesty, Joel Bowen, Suman Sood, Craig Kessler, MaissaaJanbain, Miguel Escobar, Doris Quon, American Society of Hematology, New Orleans, LA, 12/12/2022
- Pharmacokinetics of Intravenous Infusion of Glu-Plasminogen Concentrate in Patients with HypoplasminogenemiaHardesty, BM; Plum, S; Thibaudeau, K; Lee, M; Thukral, N; Shapiro, AD, American Society of Hematology, Orlando, FL, 12/7/2015
- Lineage-specific Chimerism Analysis of Post-infusion, Pre-engraftment Sorted Peripheral Blood Cells after Minimal Intensity AllotransplantationHardesty, Brandon M; Pike, Jason; Al Baghdadi, Tareq; Srivastava, Shivani; Schwartz, Jennifer E; Robertson, Michael J; Rojas, Luis A; Wood, Lisa L; Abonour, Rafat; Far..., Federation of Clinical Immunology Societies, Vancouver, Canada
- Join now to see all
Lectures
- Introduction to Hemophilia Gene TherapyVirtual - 9/2023
- Surgical Prophylaxis in vWD: Maintaining the BalanceWorld Federation of Hemophilia Orlando, FL - 7/25/2016
- Emergency Management of the Bleeding PatientMemorial Hospital of South Bend - 4/29/2015
- Join now to see all
Other
- Emergency Management of the Bleeding PatientBrandon M. Hardesty, MD
http://www.ihtc.org/cme/embp/
CME Module - 12/18/2015
Authored Content
- Plasminogen Deficiency6/1/2018
Press Mentions
Pharmaceutical companies seek FDA approval for new sickle cell cure via gene therapyOctober 31st, 2023
Advocates Raising Awareness of Sickle Cell DiseaseFebruary 10th, 2024
Grant Support
- Indiana Sickle Cell Data Collection ProgramCenters for Disease Control2023–2028
- Sickle Cell Treatment Demonstration Program Regional CollaborativeDepartment of Health and Human Services, Health Resources & Services Administration2014–2025
- Prospective Management of Cardiovascular DiseaseBayer Healthcare Pharmaceuticals, Inc2020–2023
Committees
- Member, MASAC Geriatric Workgroup 2024 - 2024
Professional Memberships
- Member
- Member
- International Society on Thrombosis and HaemostasisMember
- World Federation of HemophiliaMember
Industry Relationships
- Consultant, PSI CRODisclosure: All fees are donated to the Indiana Hemophilia and Thrombosis Center.2023 - Present
- Travel and Research support, Global Blood TherapeuticsDisclosure: All fees and honoraria are donated to the Indiana Hemophilia and Thrombosis Center.2017 - 2017
- Research, Travel, Advisory Board, and Speaker, Shire Pharmaceuticals (formerly Baxalta)Disclosure: All fees are donated to the Indiana Hemophilia and Thrombosis Center.2015 - 2017
- Consultant, Travel, and Advisory Board, Novo NordiskDisclosure: All fees are donated to the Indiana Hemophilia and Thrombosis Center2014 - 2017
- Consultant, OctapharmaDisclosure: All fees are donated to the Indiana Hemophilia and Thrombosis Center.2016 - 2016
- Research Funding, ProMetic Biotherapeutics2015 - 2016
- Consultant, BiogenDisclosure: All fees are donated to the Indiana Hemophilia and Thrombosis Center.2015 - 2015
External Links
- LinkedInhttp://www.linkedin.com/pub/brandon-hardesty-md/a0/a70/316/
- IHTChttp://www.ihtc.org
- ResearchGatehttps://www.researchgate.net/profile/Brandon_Hardesty
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
